{ "name": "BioMarin Pharmaceutical Inc.", "slug": "biomarin-pharmaceutical-inc", "description": "Statiskt källarkiv med kurshistorik, finansiella rapporter och regulatoriska dokument. För nordiska bolag används Nasdaq Nordic primärt och MFN endast för saknade rapportperioder.", "status": "complete", "updated_at": "2026-08-06T07:27:23Z", "nasdaq_status": "retrieved", "latest_market": "2026-08-05: stängning 59.91, volym 1685604", "mfn_status": "skipped", "mfn_count": 0, "nasdaq_reports_status": "skipped", "reports": { "available": false, "url": "/company/biomarin-pharmaceutical-inc/reports", "count": 0, "nasdaq_count": 0, "mfn_fallback_count": 0, "items": [] }, "report_count": 0, "nasdaq_report_count": 0, "mfn_fallback_count": 0, "sec_status": "retrieved", "sec_count": 49, "fi_status": "skipped", "fi_summary": {}, "warnings": [], "source_identity": { "nasdaq_reports": null, "mfn": null, "sec": { "status": "resolved", "method": "explicit_ticker", "expected_name": "BioMarin Pharmaceutical Inc.", "ticker": "BMRN", "title": "BIOMARIN PHARMACEUTICAL INC", "cik": "0001048477", "match_score": 100.0 }, "nasdaq": null, "finansinspektionen": null }, "documents": [ { "doc_id": "sec-edgar-8-k-2026-07-13-bmrn-20260427-htm", "title": "8-K – 2026-07-13 – bmrn-20260427.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847726000011/bmrn-20260427.htm", "date": "2026-07-13", "period": "2026-04-27", "form_type": "8-K", "report_key": null, "filename": "bmrn-20260427.htm", "text_chars": 5381, "sha256": "113fb6f6762f5f1b0426f56faaa0c1b988bd11279b2b6ca14c92878162207330", "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-07-13-bmrn-20260427-htm", "absolute_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-07-13-bmrn-20260427-htm", "txt_url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-07-13-bmrn-20260427-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-07-13-bmrn-20260427-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-07-13-bmrn-20260427-htm/part-001.html", "chars": 5381 } ] }, { "doc_id": "sec-edgar-8-k-2026-06-04-bmrn-20260602-htm", "title": "8-K – 2026-06-04 – bmrn-20260602.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1048477/000162828026040812/bmrn-20260602.htm", "date": "2026-06-04", "period": "2026-06-02", "form_type": "8-K", "report_key": null, "filename": "bmrn-20260602.htm", "text_chars": 6769, "sha256": "cc4a5f5bad521a259e0ff80221cc1a7f0eb05bec9d4cdfec09f6e40fce351065", "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-06-04-bmrn-20260602-htm", "absolute_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-06-04-bmrn-20260602-htm", "txt_url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-06-04-bmrn-20260602-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-06-04-bmrn-20260602-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-06-04-bmrn-20260602-htm/part-001.html", "chars": 6769 } ] }, { "doc_id": "sec-edgar-10-q-2026-05-05-bmrn-20260331-htm", "title": "10-Q – 2026-05-05 – bmrn-20260331.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847726000008/bmrn-20260331.htm", "date": "2026-05-05", "period": "2026-03-31", "form_type": "10-Q", "report_key": null, "filename": "bmrn-20260331.htm", "text_chars": 323706, "sha256": "38ad057e52c52d94323dd26bfd8bb0fcf423765d368a0cfab03fce9e5a3e39b4", "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-10-q-2026-05-05-bmrn-20260331-htm", "absolute_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-10-q-2026-05-05-bmrn-20260331-htm", "txt_url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-10-q-2026-05-05-bmrn-20260331-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-10-q-2026-05-05-bmrn-20260331-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-10-q-2026-05-05-bmrn-20260331-htm/part-001.html", "chars": 174435 }, { "number": 2, "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-10-q-2026-05-05-bmrn-20260331-htm/part-002.html", "chars": 149269 } ] }, { "doc_id": "sec-edgar-8-k-2026-05-04-bmrn-20260504-htm", "title": "8-K – 2026-05-04 – bmrn-20260504.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847726000006/bmrn-20260504.htm", "date": "2026-05-04", "period": "2026-05-04", "form_type": "8-K", "report_key": null, "filename": "bmrn-20260504.htm", "text_chars": 3638, "sha256": "88ff79b12ce3aa9151915d9918e701bc119f3d5c4dc1c3ab8c21ae4d875ee287", "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-05-04-bmrn-20260504-htm", "absolute_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-05-04-bmrn-20260504-htm", "txt_url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-05-04-bmrn-20260504-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-05-04-bmrn-20260504-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-05-04-bmrn-20260504-htm/part-001.html", "chars": 3638 } ] }, { "doc_id": "sec-edgar-8-k-2026-04-27-d113922d8k-htm", "title": "8-K – 2026-04-27 – d113922d8k.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312526179243/d113922d8k.htm", "date": "2026-04-27", "period": "2026-04-27", "form_type": "8-K", "report_key": null, "filename": "d113922d8k.htm", "text_chars": 13765, "sha256": "c9123f11998ac5b456598de79026de377323da58c61d31385af3a56315c9c540", "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-04-27-d113922d8k-htm", "absolute_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-04-27-d113922d8k-htm", "txt_url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-04-27-d113922d8k-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-04-27-d113922d8k-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-04-27-d113922d8k-htm/part-001.html", "chars": 13765 } ] }, { "doc_id": "sec-edgar-8-k-2026-04-23-d139584d8k-htm", "title": "8-K – 2026-04-23 – d139584d8k.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312526173770/d139584d8k.htm", "date": "2026-04-23", "period": "2026-04-23", "form_type": "8-K", "report_key": null, "filename": "d139584d8k.htm", "text_chars": 6077, "sha256": "8b6ff8df095c073819069cd4fdf271aff6f9b2c2b5cf23f1ad39b1e107ff9ef8", "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-04-23-d139584d8k-htm", "absolute_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-04-23-d139584d8k-htm", "txt_url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-04-23-d139584d8k-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-04-23-d139584d8k-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-04-23-d139584d8k-htm/part-001.html", "chars": 6077 } ] }, { "doc_id": "sec-edgar-8-k-2026-03-16-d114815d8k-htm", "title": "8-K – 2026-03-16 – d114815d8k.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312526107314/d114815d8k.htm", "date": "2026-03-16", "period": "2026-03-16", "form_type": "8-K", "report_key": null, "filename": "d114815d8k.htm", "text_chars": 5553, "sha256": "a6484a9ea091d8a2c3a5f03b2be213372f5b171db018826955731626a7fc83ea", "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-03-16-d114815d8k-htm", "absolute_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-03-16-d114815d8k-htm", "txt_url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-03-16-d114815d8k-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-03-16-d114815d8k-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-03-16-d114815d8k-htm/part-001.html", "chars": 5553 } ] }, { "doc_id": "sec-edgar-10-k-2026-02-26-bmrn-20251231-htm", "title": "10-K – 2026-02-26 – bmrn-20251231.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847726000004/bmrn-20251231.htm", "date": "2026-02-26", "period": "2025-12-31", "form_type": "10-K", "report_key": null, "filename": "bmrn-20251231.htm", "text_chars": 577283, "sha256": "8f634f3cfaf18576f14d7d8aed789cf28b1521bc4ef85b96230b6527e3535fb5", "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-10-k-2026-02-26-bmrn-20251231-htm", "absolute_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-10-k-2026-02-26-bmrn-20251231-htm", "txt_url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-10-k-2026-02-26-bmrn-20251231-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-10-k-2026-02-26-bmrn-20251231-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-10-k-2026-02-26-bmrn-20251231-htm/part-001.html", "chars": 176910 }, { "number": 2, "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-10-k-2026-02-26-bmrn-20251231-htm/part-002.html", "chars": 177923 }, { "number": 3, "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-10-k-2026-02-26-bmrn-20251231-htm/part-003.html", "chars": 179784 }, { "number": 4, "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-10-k-2026-02-26-bmrn-20251231-htm/part-004.html", "chars": 42658 } ] }, { "doc_id": "sec-edgar-8-k-2026-02-23-bmrn-20260223-htm", "title": "8-K – 2026-02-23 – bmrn-20260223.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847726000002/bmrn-20260223.htm", "date": "2026-02-23", "period": "2026-02-23", "form_type": "8-K", "report_key": null, "filename": "bmrn-20260223.htm", "text_chars": 3672, "sha256": "b78099cedba18e3196470827da1dae014ccd90d0b96d52805ac772e94b7733f3", "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-02-23-bmrn-20260223-htm", "absolute_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-02-23-bmrn-20260223-htm", "txt_url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-02-23-bmrn-20260223-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-02-23-bmrn-20260223-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-02-23-bmrn-20260223-htm/part-001.html", "chars": 3672 } ] }, { "doc_id": "sec-edgar-8-k-2026-02-12-d63881d8k-htm", "title": "8-K – 2026-02-12 – d63881d8k.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312526048736/d63881d8k.htm", "date": "2026-02-12", "period": "2026-02-12", "form_type": "8-K", "report_key": null, "filename": "d63881d8k.htm", "text_chars": 11574, "sha256": "687774aa1fc771fe4a3fec2e509cf9cbb8911edfee58fdb64cdb33bc3e6efe25", "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-02-12-d63881d8k-htm", "absolute_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-02-12-d63881d8k-htm", "txt_url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-02-12-d63881d8k-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-02-12-d63881d8k-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-02-12-d63881d8k-htm/part-001.html", "chars": 11574 } ] }, { "doc_id": "sec-edgar-8-k-2026-01-29-d170996d8k-htm", "title": "8-K – 2026-01-29 – d170996d8k.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312526029401/d170996d8k.htm", "date": "2026-01-29", "period": "2026-01-29", "form_type": "8-K", "report_key": null, "filename": "d170996d8k.htm", "text_chars": 10992, "sha256": "2de806e575ace6b18ffc8cb08bfccf1f2b6925231e0e8feab3eb13cf5df3c16b", "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-01-29-d170996d8k-htm", "absolute_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-01-29-d170996d8k-htm", "txt_url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-01-29-d170996d8k-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-01-29-d170996d8k-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-01-29-d170996d8k-htm/part-001.html", "chars": 10992 } ] }, { "doc_id": "sec-edgar-8-k-2026-01-26-d100834d8k-htm", "title": "8-K – 2026-01-26 – d100834d8k.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312526021718/d100834d8k.htm", "date": "2026-01-26", "period": "2026-01-26", "form_type": "8-K", "report_key": null, "filename": "d100834d8k.htm", "text_chars": 12355, "sha256": "4a93b966cb41508496e159e8c19e775b7c9426c6b7f4e57f793ba991dc5c3082", "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-01-26-d100834d8k-htm", "absolute_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-01-26-d100834d8k-htm", "txt_url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-01-26-d100834d8k-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-01-26-d100834d8k-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-01-26-d100834d8k-htm/part-001.html", "chars": 12355 } ] }, { "doc_id": "sec-edgar-8-k-2026-01-12-d93149d8k-htm", "title": "8-K – 2026-01-12 – d93149d8k.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312526010508/d93149d8k.htm", "date": "2026-01-12", "period": "2026-01-12", "form_type": "8-K", "report_key": null, "filename": "d93149d8k.htm", "text_chars": 10121, "sha256": "c138f64f8c4f258cec6f56b4648831d3a47f08333d1aab43df33caec93b47dc7", "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-01-12-d93149d8k-htm", "absolute_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-01-12-d93149d8k-htm", "txt_url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-01-12-d93149d8k-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-01-12-d93149d8k-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-01-12-d93149d8k-htm/part-001.html", "chars": 10121 } ] }, { "doc_id": "sec-edgar-8-k-2025-12-22-d45090d8k-htm", "title": "8-K – 2025-12-22 – d45090d8k.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312525327828/d45090d8k.htm", "date": "2025-12-22", "period": "2025-12-19", "form_type": "8-K", "report_key": null, "filename": "d45090d8k.htm", "text_chars": 2839, "sha256": "7ca41aca57ac1e76092efcb25286fff2e02b5412bbbb13ca258cca81326d7297", "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-12-22-d45090d8k-htm", "absolute_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-12-22-d45090d8k-htm", "txt_url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-12-22-d45090d8k-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-12-22-d45090d8k-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-12-22-d45090d8k-htm/part-001.html", "chars": 2839 } ] }, { "doc_id": "sec-edgar-8-k-2025-12-19-d49247d8k-htm", "title": "8-K – 2025-12-19 – d49247d8k.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312525325856/d49247d8k.htm", "date": "2025-12-19", "period": "2025-12-19", "form_type": "8-K", "report_key": null, "filename": "d49247d8k.htm", "text_chars": 26181, "sha256": "ae23cff2af573aa606443c89b8b13002cb9941941500f383449c574c145ab4b6", "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-12-19-d49247d8k-htm", "absolute_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-12-19-d49247d8k-htm", "txt_url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-12-19-d49247d8k-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-12-19-d49247d8k-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-12-19-d49247d8k-htm/part-001.html", "chars": 26181 } ] }, { "doc_id": "sec-edgar-8-k-2025-12-17-d848371d8k-htm", "title": "8-K – 2025-12-17 – d848371d8k.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312525322704/d848371d8k.htm", "date": "2025-12-17", "period": "2025-12-11", "form_type": "8-K", "report_key": null, "filename": "d848371d8k.htm", "text_chars": 6399, "sha256": "bc1de8bb15f5ba68b8a1429484b86e77d6d59d14f2a8489b3872edc2d4666c38", "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-12-17-d848371d8k-htm", "absolute_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-12-17-d848371d8k-htm", "txt_url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-12-17-d848371d8k-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-12-17-d848371d8k-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-12-17-d848371d8k-htm/part-001.html", "chars": 6399 } ] }, { "doc_id": "sec-edgar-10-q-2025-10-28-bmrn-20250930-htm", "title": "10-Q – 2025-10-28 – bmrn-20250930.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847725000107/bmrn-20250930.htm", "date": "2025-10-28", "period": "2025-09-30", "form_type": "10-Q", "report_key": null, "filename": "bmrn-20250930.htm", "text_chars": 313075, "sha256": "5f29a90bc2be0ee766497c98087824a6aa844c64a016fd44ada2b7be449c7928", "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-10-q-2025-10-28-bmrn-20250930-htm", "absolute_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-10-q-2025-10-28-bmrn-20250930-htm", "txt_url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-10-q-2025-10-28-bmrn-20250930-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-10-q-2025-10-28-bmrn-20250930-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-10-q-2025-10-28-bmrn-20250930-htm/part-001.html", "chars": 177431 }, { "number": 2, "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-10-q-2025-10-28-bmrn-20250930-htm/part-002.html", "chars": 135642 } ] }, { "doc_id": "sec-edgar-8-k-2025-10-27-bmrn-20251027-htm", "title": "8-K – 2025-10-27 – bmrn-20251027.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847725000104/bmrn-20251027.htm", "date": "2025-10-27", "period": "2025-10-27", "form_type": "8-K", "report_key": null, "filename": "bmrn-20251027.htm", "text_chars": 3667, "sha256": "6fd5617207ecafe634730dec1c68d314a3f18118d36b3a77222c1ee181a154d9", "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-10-27-bmrn-20251027-htm", "absolute_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-10-27-bmrn-20251027-htm", "txt_url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-10-27-bmrn-20251027-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-10-27-bmrn-20251027-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-10-27-bmrn-20251027-htm/part-001.html", "chars": 3667 } ] }, { "doc_id": "sec-edgar-8-k-2025-10-07-bmrn-20251007-htm", "title": "8-K – 2025-10-07 – bmrn-20251007.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847725000101/bmrn-20251007.htm", "date": "2025-10-07", "period": "2025-10-07", "form_type": "8-K", "report_key": null, "filename": "bmrn-20251007.htm", "text_chars": 8712, "sha256": "8270330b29cddf0a48aa7a2c3fef7c4a006fd8837100007a52940223f9e963aa", "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-10-07-bmrn-20251007-htm", "absolute_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-10-07-bmrn-20251007-htm", "txt_url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-10-07-bmrn-20251007-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-10-07-bmrn-20251007-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-10-07-bmrn-20251007-htm/part-001.html", "chars": 8712 } ] }, { "doc_id": "sec-edgar-8-k-2025-08-11-bmrn-20250805-htm", "title": "8-K – 2025-08-11 – bmrn-20250805.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847725000098/bmrn-20250805.htm", "date": "2025-08-11", "period": "2025-08-05", "form_type": "8-K", "report_key": null, "filename": "bmrn-20250805.htm", "text_chars": 4014, "sha256": "df92ff0e51752e8d7fe7c3c0b3cdf0d6117422338be4a8a8babfb46e0b7febdc", "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-08-11-bmrn-20250805-htm", "absolute_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-08-11-bmrn-20250805-htm", "txt_url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-08-11-bmrn-20250805-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-08-11-bmrn-20250805-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-08-11-bmrn-20250805-htm/part-001.html", "chars": 4014 } ] } ], "market_files": [ { "label": "Nasdaq kurshistorik CSV", "url": "/company/biomarin-pharmaceutical-inc/market/history.csv", "absolute_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/market/history.csv" }, { "label": "Nasdaq kurshistorik JSON", "url": "/company/biomarin-pharmaceutical-inc/market/history.json", "absolute_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/market/history.json" }, { "label": "Nasdaq manifest JSON", "url": "/company/biomarin-pharmaceutical-inc/market/manifest.json", "absolute_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/market/manifest.json" }, { "label": "SEC Company Facts JSON", "url": "/company/biomarin-pharmaceutical-inc/market/sec-companyfacts.json", "absolute_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/market/sec-companyfacts.json" }, { "label": "SEC filing-manifest JSON", "url": "/company/biomarin-pharmaceutical-inc/market/sec-manifest.json", "absolute_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/market/sec-manifest.json" }, { "label": "SEC sammanfattning JSON", "url": "/company/biomarin-pharmaceutical-inc/market/sec-summary.json", "absolute_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc/market/sec-summary.json" } ], "sec_facts": { "status": "summarized", "entity_name": "BioMarin Pharmaceutical Inc", "cik": 1048477, "metrics": [ { "label": "Intäkter", "taxonomy": "us-gaap", "concept": "RevenueFromContractWithCustomerExcludingAssessedTax", "description": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label_original": "Revenue from Contract with Customer, Excluding Assessed Tax", "facts": [ { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2026-01-01", "end": "2026-03-31", "filed": "2026-05-05", "value": 766208000, "unit": "USD", "accession": "0001048477-26-000008", "frame": "CY2026Q1" }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2025-01-01", "end": "2025-03-31", "filed": "2026-05-05", "value": 745145000, "unit": "USD", "accession": "0001048477-26-000008", "frame": "CY2025Q1" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2025-01-01", "end": "2025-12-31", "filed": "2026-02-26", "value": 3221253000, "unit": "USD", "accession": "0001048477-26-000004", "frame": "CY2025" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2024-01-01", "end": "2024-12-31", "filed": "2026-02-26", "value": 2853915000, "unit": "USD", "accession": "0001048477-26-000004", "frame": "CY2024" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2023-01-01", "end": "2023-12-31", "filed": "2026-02-26", "value": 2419226000, "unit": "USD", "accession": "0001048477-26-000004", "frame": "CY2023" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2025-01-01", "end": "2025-09-30", "filed": "2025-10-28", "value": 2346688000, "unit": "USD", "accession": "0001048477-25-000107", "frame": null }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2024-01-01", "end": "2024-09-30", "filed": "2025-10-28", "value": 2106602000, "unit": "USD", "accession": "0001048477-25-000107", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2025-01-01", "end": "2025-06-30", "filed": "2025-08-05", "value": 1570555000, "unit": "USD", "accession": "0001048477-25-000090", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2024-01-01", "end": "2024-06-30", "filed": "2025-08-05", "value": 1360862000, "unit": "USD", "accession": "0001048477-25-000090", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2025-01-01", "end": "2025-03-31", "filed": "2025-05-02", "value": 745145000, "unit": "USD", "accession": "0001048477-25-000051", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2024-01-01", "end": "2024-03-31", "filed": "2025-05-02", "value": 648833000, "unit": "USD", "accession": "0001048477-25-000051", "frame": "CY2024Q1" }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2024-01-01", "end": "2024-12-31", "filed": "2025-02-24", "value": 2853915000, "unit": "USD", "accession": "0001048477-25-000007", "frame": null }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2023-01-01", "end": "2023-12-31", "filed": "2025-02-24", "value": 2419226000, "unit": "USD", "accession": "0001048477-25-000007", "frame": null }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2022-01-01", "end": "2022-12-31", "filed": "2025-02-24", "value": 2096039000, "unit": "USD", "accession": "0001048477-25-000007", "frame": "CY2022" }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": "2024-01-01", "end": "2024-09-30", "filed": "2024-10-31", "value": 2106602000, "unit": "USD", "accession": "0001048477-24-000152", "frame": null }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": "2023-01-01", "end": "2023-09-30", "filed": "2024-10-31", "value": 1773019000, "unit": "USD", "accession": "0001048477-24-000152", "frame": null } ] }, { "label": "Rörelseresultat", "taxonomy": "us-gaap", "concept": "OperatingIncomeLoss", "description": "The net result for the period of deducting operating expenses from operating revenues.", "label_original": "Operating Income (Loss)", "facts": [ { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2026-01-01", "end": "2026-03-31", "filed": "2026-05-05", "value": 129640000, "unit": "USD", "accession": "0001048477-26-000008", "frame": "CY2026Q1" }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2025-01-01", "end": "2025-03-31", "filed": "2026-05-05", "value": 223893000, "unit": "USD", "accession": "0001048477-26-000008", "frame": "CY2025Q1" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2025-01-01", "end": "2025-12-31", "filed": "2026-02-26", "value": 409478000, "unit": "USD", "accession": "0001048477-26-000004", "frame": "CY2025" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2024-01-01", "end": "2024-12-31", "filed": "2026-02-26", "value": 484214000, "unit": "USD", "accession": "0001048477-26-000004", "frame": "CY2024" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2023-01-01", "end": "2023-12-31", "filed": "2026-02-26", "value": 185774000, "unit": "USD", "accession": "0001048477-26-000004", "frame": "CY2023" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2025-01-01", "end": "2025-09-30", "filed": "2025-10-28", "value": 454088000, "unit": "USD", "accession": "0001048477-25-000107", "frame": null }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2024-01-01", "end": "2024-09-30", "filed": "2025-10-28", "value": 322807000, "unit": "USD", "accession": "0001048477-25-000107", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2025-01-01", "end": "2025-06-30", "filed": "2025-08-05", "value": 500780000, "unit": "USD", "accession": "0001048477-25-000090", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2024-01-01", "end": "2024-06-30", "filed": "2025-08-05", "value": 208914000, "unit": "USD", "accession": "0001048477-25-000090", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2025-01-01", "end": "2025-03-31", "filed": "2025-05-02", "value": 223893000, "unit": "USD", "accession": "0001048477-25-000051", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2024-01-01", "end": "2024-03-31", "filed": "2025-05-02", "value": 88462000, "unit": "USD", "accession": "0001048477-25-000051", "frame": "CY2024Q1" }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2024-01-01", "end": "2024-12-31", "filed": "2025-02-24", "value": 484214000, "unit": "USD", "accession": "0001048477-25-000007", "frame": null }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2023-01-01", "end": "2023-12-31", "filed": "2025-02-24", "value": 185774000, "unit": "USD", "accession": "0001048477-25-000007", "frame": null }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2022-01-01", "end": "2022-12-31", "filed": "2025-02-24", "value": 160974000, "unit": "USD", "accession": "0001048477-25-000007", "frame": "CY2022" }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": "2024-01-01", "end": "2024-09-30", "filed": "2024-10-31", "value": 322807000, "unit": "USD", "accession": "0001048477-24-000152", "frame": null }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": "2023-01-01", "end": "2023-09-30", "filed": "2024-10-31", "value": 158495000, "unit": "USD", "accession": "0001048477-24-000152", "frame": null } ] }, { "label": "Nettoresultat", "taxonomy": "us-gaap", "concept": "NetIncomeLoss", "description": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label_original": "Net Income (Loss) Attributable to Parent", "facts": [ { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2026-01-01", "end": "2026-03-31", "filed": "2026-05-05", "value": 105527000, "unit": "USD", "accession": "0001048477-26-000008", "frame": "CY2026Q1" }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2025-01-01", "end": "2025-03-31", "filed": "2026-05-05", "value": 185686000, "unit": "USD", "accession": "0001048477-26-000008", "frame": "CY2025Q1" }, { "fy": null, "fp": null, "form": "DEF 14A", "start": "2025-01-01", "end": "2025-12-31", "filed": "2026-04-21", "value": 348900000, "unit": "USD", "accession": "0001628280-26-026290", "frame": "CY2025" }, { "fy": null, "fp": null, "form": "DEF 14A", "start": "2024-01-01", "end": "2024-12-31", "filed": "2026-04-21", "value": 426900000, "unit": "USD", "accession": "0001628280-26-026290", "frame": "CY2024" }, { "fy": null, "fp": null, "form": "DEF 14A", "start": "2023-01-01", "end": "2023-12-31", "filed": "2026-04-21", "value": 167600000, "unit": "USD", "accession": "0001628280-26-026290", "frame": "CY2023" }, { "fy": null, "fp": null, "form": "DEF 14A", "start": "2022-01-01", "end": "2022-12-31", "filed": "2026-04-21", "value": 141600000, "unit": "USD", "accession": "0001628280-26-026290", "frame": "CY2022" }, { "fy": null, "fp": null, "form": "DEF 14A", "start": "2021-01-01", "end": "2021-12-31", "filed": "2026-04-21", "value": -64100000, "unit": "USD", "accession": "0001628280-26-026290", "frame": "CY2021" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2025-01-01", "end": "2025-12-31", "filed": "2026-02-26", "value": 348901000, "unit": "USD", "accession": "0001048477-26-000004", "frame": null }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2024-01-01", "end": "2024-12-31", "filed": "2026-02-26", "value": 426859000, "unit": "USD", "accession": "0001048477-26-000004", "frame": null }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2023-01-01", "end": "2023-12-31", "filed": "2026-02-26", "value": 167645000, "unit": "USD", "accession": "0001048477-26-000004", "frame": null }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2025-01-01", "end": "2025-09-30", "filed": "2025-10-28", "value": 395474000, "unit": "USD", "accession": "0001048477-25-000107", "frame": null }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2024-01-01", "end": "2024-09-30", "filed": "2025-10-28", "value": 301916000, "unit": "USD", "accession": "0001048477-25-000107", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2025-01-01", "end": "2025-06-30", "filed": "2025-08-05", "value": 426218000, "unit": "USD", "accession": "0001048477-25-000090", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2024-01-01", "end": "2024-06-30", "filed": "2025-08-05", "value": 195836000, "unit": "USD", "accession": "0001048477-25-000090", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2025-01-01", "end": "2025-03-31", "filed": "2025-05-02", "value": 185686000, "unit": "USD", "accession": "0001048477-25-000051", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2024-01-01", "end": "2024-03-31", "filed": "2025-05-02", "value": 88662000, "unit": "USD", "accession": "0001048477-25-000051", "frame": "CY2024Q1" } ] }, { "label": "Resultat per aktie, utspätt", "taxonomy": "us-gaap", "concept": "EarningsPerShareDiluted", "description": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label_original": "Earnings Per Share, Diluted", "facts": [ { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2026-01-01", "end": "2026-03-31", "filed": "2026-05-05", "value": 0.54, "unit": "USD/shares", "accession": "0001048477-26-000008", "frame": "CY2026Q1" }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2025-01-01", "end": "2025-03-31", "filed": "2026-05-05", "value": 0.95, "unit": "USD/shares", "accession": "0001048477-26-000008", "frame": "CY2025Q1" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2025-01-01", "end": "2025-12-31", "filed": "2026-02-26", "value": 1.8, "unit": "USD/shares", "accession": "0001048477-26-000004", "frame": "CY2025" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2024-01-01", "end": "2024-12-31", "filed": "2026-02-26", "value": 2.21, "unit": "USD/shares", "accession": "0001048477-26-000004", "frame": "CY2024" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2023-01-01", "end": "2023-12-31", "filed": "2026-02-26", "value": 0.87, "unit": "USD/shares", "accession": "0001048477-26-000004", "frame": "CY2023" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2025-01-01", "end": "2025-09-30", "filed": "2025-10-28", "value": 2.04, "unit": "USD/shares", "accession": "0001048477-25-000107", "frame": null }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2024-01-01", "end": "2024-09-30", "filed": "2025-10-28", "value": 1.56, "unit": "USD/shares", "accession": "0001048477-25-000107", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2025-01-01", "end": "2025-06-30", "filed": "2025-08-05", "value": 2.19, "unit": "USD/shares", "accession": "0001048477-25-000090", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2024-01-01", "end": "2024-06-30", "filed": "2025-08-05", "value": 1.01, "unit": "USD/shares", "accession": "0001048477-25-000090", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2025-01-01", "end": "2025-03-31", "filed": "2025-05-02", "value": 0.95, "unit": "USD/shares", "accession": "0001048477-25-000051", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2024-01-01", "end": "2024-03-31", "filed": "2025-05-02", "value": 0.46, "unit": "USD/shares", "accession": "0001048477-25-000051", "frame": "CY2024Q1" }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2024-01-01", "end": "2024-12-31", "filed": "2025-02-24", "value": 2.21, "unit": "USD/shares", "accession": "0001048477-25-000007", "frame": null }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2023-01-01", "end": "2023-12-31", "filed": "2025-02-24", "value": 0.87, "unit": "USD/shares", "accession": "0001048477-25-000007", "frame": null }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2022-01-01", "end": "2022-12-31", "filed": "2025-02-24", "value": 0.75, "unit": "USD/shares", "accession": "0001048477-25-000007", "frame": "CY2022" }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": "2024-01-01", "end": "2024-09-30", "filed": "2024-10-31", "value": 1.56, "unit": "USD/shares", "accession": "0001048477-24-000152", "frame": null }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": "2023-01-01", "end": "2023-09-30", "filed": "2024-10-31", "value": 0.77, "unit": "USD/shares", "accession": "0001048477-24-000152", "frame": null } ] }, { "label": "Kassa", "taxonomy": "us-gaap", "concept": "CashAndCashEquivalentsAtCarryingValue", "description": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label_original": "Cash and Cash Equivalents, at Carrying Value", "facts": [ { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": null, "end": "2026-03-31", "filed": "2026-05-05", "value": 2222435000, "unit": "USD", "accession": "0001048477-26-000008", "frame": "CY2026Q1I" }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": null, "end": "2025-12-31", "filed": "2026-05-05", "value": 1311679000, "unit": "USD", "accession": "0001048477-26-000008", "frame": "CY2025Q4I" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": null, "end": "2025-12-31", "filed": "2026-02-26", "value": 1311679000, "unit": "USD", "accession": "0001048477-26-000004", "frame": null }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": null, "end": "2024-12-31", "filed": "2026-02-26", "value": 942842000, "unit": "USD", "accession": "0001048477-26-000004", "frame": "CY2024Q4I" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": null, "end": "2025-09-30", "filed": "2025-10-28", "value": 1250108000, "unit": "USD", "accession": "0001048477-25-000107", "frame": "CY2025Q3I" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": null, "end": "2024-12-31", "filed": "2025-10-28", "value": 942842000, "unit": "USD", "accession": "0001048477-25-000107", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": null, "end": "2025-06-30", "filed": "2025-08-05", "value": 1213816000, "unit": "USD", "accession": "0001048477-25-000090", "frame": "CY2025Q2I" }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": null, "end": "2024-12-31", "filed": "2025-08-05", "value": 942842000, "unit": "USD", "accession": "0001048477-25-000090", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": null, "end": "2025-03-31", "filed": "2025-05-02", "value": 1048803000, "unit": "USD", "accession": "0001048477-25-000051", "frame": "CY2025Q1I" }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": null, "end": "2024-12-31", "filed": "2025-05-02", "value": 942842000, "unit": "USD", "accession": "0001048477-25-000051", "frame": null }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": null, "end": "2024-12-31", "filed": "2025-02-24", "value": 942842000, "unit": "USD", "accession": "0001048477-25-000007", "frame": null }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": null, "end": "2023-12-31", "filed": "2025-02-24", "value": 755127000, "unit": "USD", "accession": "0001048477-25-000007", "frame": "CY2023Q4I" }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": null, "end": "2024-09-30", "filed": "2024-10-31", "value": 675448000, "unit": "USD", "accession": "0001048477-24-000152", "frame": "CY2024Q3I" }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": null, "end": "2023-12-31", "filed": "2024-10-31", "value": 755127000, "unit": "USD", "accession": "0001048477-24-000152", "frame": null }, { "fy": 2024, "fp": "Q2", "form": "10-Q", "start": null, "end": "2024-06-30", "filed": "2024-08-05", "value": 972150000, "unit": "USD", "accession": "0001048477-24-000126", "frame": "CY2024Q2I" }, { "fy": 2024, "fp": "Q2", "form": "10-Q", "start": null, "end": "2023-12-31", "filed": "2024-08-05", "value": 755127000, "unit": "USD", "accession": "0001048477-24-000126", "frame": null } ] }, { "label": "Tillgångar", "taxonomy": "us-gaap", "concept": "Assets", "description": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label_original": "Assets", "facts": [ { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": null, "end": "2026-03-31", "filed": "2026-05-05", "value": 8591016000, "unit": "USD", "accession": "0001048477-26-000008", "frame": "CY2026Q1I" }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": null, "end": "2025-12-31", "filed": "2026-05-05", "value": 7594022000, "unit": "USD", "accession": "0001048477-26-000008", "frame": "CY2025Q4I" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": null, "end": "2025-12-31", "filed": "2026-02-26", "value": 7594022000, "unit": "USD", "accession": "0001048477-26-000004", "frame": null }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": null, "end": "2024-12-31", "filed": "2026-02-26", "value": 6988940000, "unit": "USD", "accession": "0001048477-26-000004", "frame": "CY2024Q4I" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": null, "end": "2025-09-30", "filed": "2025-10-28", "value": 7614868000, "unit": "USD", "accession": "0001048477-25-000107", "frame": "CY2025Q3I" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": null, "end": "2024-12-31", "filed": "2025-10-28", "value": 6988940000, "unit": "USD", "accession": "0001048477-25-000107", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": null, "end": "2025-06-30", "filed": "2025-08-05", "value": 7456341000, "unit": "USD", "accession": "0001048477-25-000090", "frame": "CY2025Q2I" }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": null, "end": "2024-12-31", "filed": "2025-08-05", "value": 6988940000, "unit": "USD", "accession": "0001048477-25-000090", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": null, "end": "2025-03-31", "filed": "2025-05-02", "value": 7147007000, "unit": "USD", "accession": "0001048477-25-000051", "frame": "CY2025Q1I" }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": null, "end": "2024-12-31", "filed": "2025-05-02", "value": 6988940000, "unit": "USD", "accession": "0001048477-25-000051", "frame": null }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": null, "end": "2024-12-31", "filed": "2025-02-24", "value": 6988940000, "unit": "USD", "accession": "0001048477-25-000007", "frame": null }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": null, "end": "2023-12-31", "filed": "2025-02-24", "value": 6841603000, "unit": "USD", "accession": "0001048477-25-000007", "frame": "CY2023Q4I" }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": null, "end": "2024-09-30", "filed": "2024-10-31", "value": 6851195000, "unit": "USD", "accession": "0001048477-24-000152", "frame": "CY2024Q3I" }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": null, "end": "2023-12-31", "filed": "2024-10-31", "value": 6841603000, "unit": "USD", "accession": "0001048477-24-000152", "frame": null }, { "fy": 2024, "fp": "Q2", "form": "10-Q", "start": null, "end": "2024-06-30", "filed": "2024-08-05", "value": 7067121000, "unit": "USD", "accession": "0001048477-24-000126", "frame": "CY2024Q2I" }, { "fy": 2024, "fp": "Q2", "form": "10-Q", "start": null, "end": "2023-12-31", "filed": "2024-08-05", "value": 6841603000, "unit": "USD", "accession": "0001048477-24-000126", "frame": null } ] }, { "label": "Skulder", "taxonomy": "us-gaap", "concept": "Liabilities", "description": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label_original": "Liabilities", "facts": [ { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": null, "end": "2026-03-31", "filed": "2026-05-05", "value": 2378909000, "unit": "USD", "accession": "0001048477-26-000008", "frame": "CY2026Q1I" }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": null, "end": "2025-12-31", "filed": "2026-05-05", "value": 1507023000, "unit": "USD", "accession": "0001048477-26-000008", "frame": "CY2025Q4I" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": null, "end": "2025-12-31", "filed": "2026-02-26", "value": 1507023000, "unit": "USD", "accession": "0001048477-26-000004", "frame": null }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": null, "end": "2024-12-31", "filed": "2026-02-26", "value": 1330950000, "unit": "USD", "accession": "0001048477-26-000004", "frame": "CY2024Q4I" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": null, "end": "2025-09-30", "filed": "2025-10-28", "value": 1558157000, "unit": "USD", "accession": "0001048477-25-000107", "frame": "CY2025Q3I" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": null, "end": "2024-12-31", "filed": "2025-10-28", "value": 1330950000, "unit": "USD", "accession": "0001048477-25-000107", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": null, "end": "2025-06-30", "filed": "2025-08-05", "value": 1429228000, "unit": "USD", "accession": "0001048477-25-000090", "frame": "CY2025Q2I" }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": null, "end": "2024-12-31", "filed": "2025-08-05", "value": 1330950000, "unit": "USD", "accession": "0001048477-25-000090", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": null, "end": "2025-03-31", "filed": "2025-05-02", "value": 1353548000, "unit": "USD", "accession": "0001048477-25-000051", "frame": "CY2025Q1I" }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": null, "end": "2024-12-31", "filed": "2025-05-02", "value": 1330950000, "unit": "USD", "accession": "0001048477-25-000051", "frame": null }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": null, "end": "2024-12-31", "filed": "2025-02-24", "value": 1330950000, "unit": "USD", "accession": "0001048477-25-000007", "frame": null }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": null, "end": "2023-12-31", "filed": "2025-02-24", "value": 1890054000, "unit": "USD", "accession": "0001048477-25-000007", "frame": "CY2023Q4I" }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": null, "end": "2024-09-30", "filed": "2024-10-31", "value": 1437799000, "unit": "USD", "accession": "0001048477-24-000152", "frame": "CY2024Q3I" }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": null, "end": "2023-12-31", "filed": "2024-10-31", "value": 1890054000, "unit": "USD", "accession": "0001048477-24-000152", "frame": null }, { "fy": 2024, "fp": "Q2", "form": "10-Q", "start": null, "end": "2024-06-30", "filed": "2024-08-05", "value": 1780822000, "unit": "USD", "accession": "0001048477-24-000126", "frame": "CY2024Q2I" }, { "fy": 2024, "fp": "Q2", "form": "10-Q", "start": null, "end": "2023-12-31", "filed": "2024-08-05", "value": 1890054000, "unit": "USD", "accession": "0001048477-24-000126", "frame": null } ] }, { "label": "Eget kapital", "taxonomy": "us-gaap", "concept": "StockholdersEquity", "description": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label_original": "Stockholders' Equity Attributable to Parent", "facts": [ { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": null, "end": "2026-03-31", "filed": "2026-05-05", "value": 6212107000, "unit": "USD", "accession": "0001048477-26-000008", "frame": "CY2026Q1I" }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": null, "end": "2025-12-31", "filed": "2026-05-05", "value": 6086999000, "unit": "USD", "accession": "0001048477-26-000008", "frame": "CY2025Q4I" }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": null, "end": "2025-03-31", "filed": "2026-05-05", "value": 5793459000, "unit": "USD", "accession": "0001048477-26-000008", "frame": "CY2025Q1I" }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": null, "end": "2024-12-31", "filed": "2026-05-05", "value": 5657990000, "unit": "USD", "accession": "0001048477-26-000008", "frame": "CY2024Q4I" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": null, "end": "2025-12-31", "filed": "2026-02-26", "value": 6086999000, "unit": "USD", "accession": "0001048477-26-000004", "frame": null }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": null, "end": "2024-12-31", "filed": "2026-02-26", "value": 5657990000, "unit": "USD", "accession": "0001048477-26-000004", "frame": null }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": null, "end": "2023-12-31", "filed": "2026-02-26", "value": 4951549000, "unit": "USD", "accession": "0001048477-26-000004", "frame": "CY2023Q4I" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": null, "end": "2022-12-31", "filed": "2026-02-26", "value": 4603156000, "unit": "USD", "accession": "0001048477-26-000004", "frame": "CY2022Q4I" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": null, "end": "2025-09-30", "filed": "2025-10-28", "value": 6056711000, "unit": "USD", "accession": "0001048477-25-000107", "frame": "CY2025Q3I" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": null, "end": "2025-06-30", "filed": "2025-10-28", "value": 6027113000, "unit": "USD", "accession": "0001048477-25-000107", "frame": "CY2025Q2I" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": null, "end": "2024-12-31", "filed": "2025-10-28", "value": 5657990000, "unit": "USD", "accession": "0001048477-25-000107", "frame": null }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": null, "end": "2024-09-30", "filed": "2025-10-28", "value": 5413396000, "unit": "USD", "accession": "0001048477-25-000107", "frame": "CY2024Q3I" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": null, "end": "2024-06-30", "filed": "2025-10-28", "value": 5286299000, "unit": "USD", "accession": "0001048477-25-000107", "frame": "CY2024Q2I" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": null, "end": "2023-12-31", "filed": "2025-10-28", "value": 4951549000, "unit": "USD", "accession": "0001048477-25-000107", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": null, "end": "2025-06-30", "filed": "2025-08-05", "value": 6027113000, "unit": "USD", "accession": "0001048477-25-000090", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": null, "end": "2025-03-31", "filed": "2025-08-05", "value": 5793459000, "unit": "USD", "accession": "0001048477-25-000090", "frame": null } ] }, { "label": "Operativt kassaflöde", "taxonomy": "us-gaap", "concept": "NetCashProvidedByUsedInOperatingActivities", "description": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label_original": "Net Cash Provided by (Used in) Operating Activities", "facts": [ { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2026-01-01", "end": "2026-03-31", "filed": "2026-05-05", "value": 220651000, "unit": "USD", "accession": "0001048477-26-000008", "frame": "CY2026Q1" }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2025-01-01", "end": "2025-03-31", "filed": "2026-05-05", "value": 174394000, "unit": "USD", "accession": "0001048477-26-000008", "frame": "CY2025Q1" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2025-01-01", "end": "2025-12-31", "filed": "2026-02-26", "value": 827994000, "unit": "USD", "accession": "0001048477-26-000004", "frame": "CY2025" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2024-01-01", "end": "2024-12-31", "filed": "2026-02-26", "value": 572841000, "unit": "USD", "accession": "0001048477-26-000004", "frame": "CY2024" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2023-01-01", "end": "2023-12-31", "filed": "2026-02-26", "value": 159259000, "unit": "USD", "accession": "0001048477-26-000004", "frame": "CY2023" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2025-01-01", "end": "2025-09-30", "filed": "2025-10-28", "value": 728350000, "unit": "USD", "accession": "0001048477-25-000107", "frame": null }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2024-01-01", "end": "2024-09-30", "filed": "2025-10-28", "value": 387214000, "unit": "USD", "accession": "0001048477-25-000107", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2025-01-01", "end": "2025-06-30", "filed": "2025-08-05", "value": 359665000, "unit": "USD", "accession": "0001048477-25-000090", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2024-01-01", "end": "2024-06-30", "filed": "2025-08-05", "value": 165733000, "unit": "USD", "accession": "0001048477-25-000090", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2025-01-01", "end": "2025-03-31", "filed": "2025-05-02", "value": 174394000, "unit": "USD", "accession": "0001048477-25-000051", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2024-01-01", "end": "2024-03-31", "filed": "2025-05-02", "value": 46971000, "unit": "USD", "accession": "0001048477-25-000051", "frame": "CY2024Q1" }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2024-01-01", "end": "2024-12-31", "filed": "2025-02-24", "value": 572841000, "unit": "USD", "accession": "0001048477-25-000007", "frame": null }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2023-01-01", "end": "2023-12-31", "filed": "2025-02-24", "value": 159259000, "unit": "USD", "accession": "0001048477-25-000007", "frame": null }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2022-01-01", "end": "2022-12-31", "filed": "2025-02-24", "value": 175902000, "unit": "USD", "accession": "0001048477-25-000007", "frame": "CY2022" }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": "2024-01-01", "end": "2024-09-30", "filed": "2024-10-31", "value": 387214000, "unit": "USD", "accession": "0001048477-24-000152", "frame": null }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": "2023-01-01", "end": "2023-09-30", "filed": "2024-10-31", "value": 131776000, "unit": "USD", "accession": "0001048477-24-000152", "frame": null } ] }, { "label": "Investeringar", "taxonomy": "us-gaap", "concept": "PaymentsToAcquirePropertyPlantAndEquipment", "description": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label_original": "Payments to Acquire Property, Plant, and Equipment", "facts": [ { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2026-01-01", "end": "2026-03-31", "filed": "2026-05-05", "value": 20923000, "unit": "USD", "accession": "0001048477-26-000008", "frame": "CY2026Q1" }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2025-01-01", "end": "2025-03-31", "filed": "2026-05-05", "value": 16768000, "unit": "USD", "accession": "0001048477-26-000008", "frame": "CY2025Q1" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2025-01-01", "end": "2025-12-31", "filed": "2026-02-26", "value": 103038000, "unit": "USD", "accession": "0001048477-26-000004", "frame": "CY2025" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2024-01-01", "end": "2024-12-31", "filed": "2026-02-26", "value": 85424000, "unit": "USD", "accession": "0001048477-26-000004", "frame": "CY2024" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2023-01-01", "end": "2023-12-31", "filed": "2026-02-26", "value": 96691000, "unit": "USD", "accession": "0001048477-26-000004", "frame": "CY2023" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2025-01-01", "end": "2025-09-30", "filed": "2025-10-28", "value": 62316000, "unit": "USD", "accession": "0001048477-25-000107", "frame": null }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2024-01-01", "end": "2024-09-30", "filed": "2025-10-28", "value": 65894000, "unit": "USD", "accession": "0001048477-25-000107", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2025-01-01", "end": "2025-06-30", "filed": "2025-08-05", "value": 33869000, "unit": "USD", "accession": "0001048477-25-000090", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2024-01-01", "end": "2024-06-30", "filed": "2025-08-05", "value": 47431000, "unit": "USD", "accession": "0001048477-25-000090", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2025-01-01", "end": "2025-03-31", "filed": "2025-05-02", "value": 16768000, "unit": "USD", "accession": "0001048477-25-000051", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2024-01-01", "end": "2024-03-31", "filed": "2025-05-02", "value": 26104000, "unit": "USD", "accession": "0001048477-25-000051", "frame": "CY2024Q1" }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2024-01-01", "end": "2024-12-31", "filed": "2025-02-24", "value": 85424000, "unit": "USD", "accession": "0001048477-25-000007", "frame": null }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2023-01-01", "end": "2023-12-31", "filed": "2025-02-24", "value": 96691000, "unit": "USD", "accession": "0001048477-25-000007", "frame": null }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2022-01-01", "end": "2022-12-31", "filed": "2025-02-24", "value": 120959000, "unit": "USD", "accession": "0001048477-25-000007", "frame": "CY2022" }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": "2024-01-01", "end": "2024-09-30", "filed": "2024-10-31", "value": 65894000, "unit": "USD", "accession": "0001048477-24-000152", "frame": null }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": "2023-01-01", "end": "2023-09-30", "filed": "2024-10-31", "value": 67774000, "unit": "USD", "accession": "0001048477-24-000152", "frame": null } ] }, { "label": "Antal aktier, utspätt", "taxonomy": "us-gaap", "concept": "WeightedAverageNumberOfDilutedSharesOutstanding", "description": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label_original": "Weighted Average Number of Shares Outstanding, Diluted", "facts": [ { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2026-01-01", "end": "2026-03-31", "filed": "2026-05-05", "value": 197671000, "unit": "shares", "accession": "0001048477-26-000008", "frame": "CY2026Q1" }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2025-01-01", "end": "2025-03-31", "filed": "2026-05-05", "value": 196474000, "unit": "shares", "accession": "0001048477-26-000008", "frame": "CY2025Q1" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2025-01-01", "end": "2025-12-31", "filed": "2026-02-26", "value": 197394000, "unit": "shares", "accession": "0001048477-26-000004", "frame": "CY2025" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2024-01-01", "end": "2024-12-31", "filed": "2026-02-26", "value": 196708000, "unit": "shares", "accession": "0001048477-26-000004", "frame": "CY2024" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2023-01-01", "end": "2023-12-31", "filed": "2026-02-26", "value": 191595000, "unit": "shares", "accession": "0001048477-26-000004", "frame": "CY2023" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2025-01-01", "end": "2025-09-30", "filed": "2025-10-28", "value": 196893000, "unit": "shares", "accession": "0001048477-25-000107", "frame": null }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2024-01-01", "end": "2024-09-30", "filed": "2025-10-28", "value": 196683000, "unit": "shares", "accession": "0001048477-25-000107", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2025-01-01", "end": "2025-06-30", "filed": "2025-08-05", "value": 196643000, "unit": "shares", "accession": "0001048477-25-000090", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2024-01-01", "end": "2024-06-30", "filed": "2025-08-05", "value": 200137000, "unit": "shares", "accession": "0001048477-25-000090", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2025-01-01", "end": "2025-03-31", "filed": "2025-05-02", "value": 196474000, "unit": "shares", "accession": "0001048477-25-000051", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2024-01-01", "end": "2024-03-31", "filed": "2025-05-02", "value": 199262000, "unit": "shares", "accession": "0001048477-25-000051", "frame": "CY2024Q1" }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2024-01-01", "end": "2024-12-31", "filed": "2025-02-24", "value": 196708000, "unit": "shares", "accession": "0001048477-25-000007", "frame": null }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2023-01-01", "end": "2023-12-31", "filed": "2025-02-24", "value": 191595000, "unit": "shares", "accession": "0001048477-25-000007", "frame": null }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2022-01-01", "end": "2022-12-31", "filed": "2025-02-24", "value": 188963000, "unit": "shares", "accession": "0001048477-25-000007", "frame": "CY2022" }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": "2024-01-01", "end": "2024-09-30", "filed": "2024-10-31", "value": 196683000, "unit": "shares", "accession": "0001048477-24-000152", "frame": null }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": "2023-01-01", "end": "2023-09-30", "filed": "2024-10-31", "value": 195042000, "unit": "shares", "accession": "0001048477-24-000152", "frame": null } ] } ] }, "morningstar": { "configured": false, "status": "inte hämtad", "captured_at": null, "view_count": 0, "url": "/company/biomarin-pharmaceutical-inc/morningstar" }, "finansinspektionen": { "available": false, "status": "skipped", "url": "/company/biomarin-pharmaceutical-inc/finansinspektionen", "transaction_count": 0, "aggregate_short_percent": null, "files": [] }, "llms_url": "/company/biomarin-pharmaceutical-inc/llms.txt", "json_url": "/company/biomarin-pharmaceutical-inc/company.json", "document_index_url": "/company/biomarin-pharmaceutical-inc/documents.json", "absolute_url": "https://spela.port0.org/company/biomarin-pharmaceutical-inc" }